About: Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article (publication date: 1999)

Attributes	Values
rdf:type	Item
description	artículu científicu espublizáu en 1999 (ast) 1999 թուականի Յունուարին հրատարակուած գիտական յօդուած (hyw) наукова стаття, опублікована в січні 1999 (uk) مقالة علمية (نشرت عام 1999) (ar) 1999 թվականի հունվարին հրատարակված գիտական հոդված (hy) article scientifique publié en 1999 (fr) wetenschappelijk artikel (gepubliceerd in 1999-01) (nl) scientific article (publication date: 1999) (en) im Jahr 1999 veröffentlichter wissenschaftlicher Artikel (de)
publication date	wds:Q29619747-DD8FD54D-A45A-484E-89AD-98FFE3FA2031
publication date	1999-01-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q29619747-D909D7A9-F0F7-4F1C-B549-6875D479BA8F
language of work or name	English
OpenCitations bibliographic resource ID	wds:Q29619747-F5446B9E-9872-41C6-A085-EE4758AAD73F
OpenCitations bibliographic resource ID	https://w3id.org/oc/corpus/br/29293
OpenCitations bibliographic resource ID	29293
rdfs:label	Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium (en) Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium (ast)
skos:prefLabel	Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium (en) Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium (ast)
name	Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium (en) Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium (ast)
title	wds:Q29619747-1D2BE56D-D7E4-4B84-9528-0EBD51ED7222
title	Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium (en)
page(s)	wds:Q29619747-14DAAFD3-9F3B-47F1-827F-4D67D63B4E01
page(s)	35-47
instance of	wds:Q29619747-11576DB5-DE60-401E-9A26-B949BA91A555
instance of	scholarly article
main subject	wds:Q29619747-0C816538-C62F-42EF-BD18-F64C421D0E8B wds:Q29619747-502C2A17-ABD1-4140-8E37-2873D3EF36AB wds:Q29619747-5F6CF90F-A0FB-4FB8-8F7E-6BEC075F74A9 wds:Q29619747-66C94924-18FE-4C7B-B7A7-A11C207F3A2B wds:Q29619747-7de0237c-4406-e1b8-fd5a-9f1dc1bb3196
main subject	Belgica metro station collaboration World Health Organization viral hepatitis Hepacivirus C
PubMed ID	wds:Q29619747-3B8898AD-1EA4-4572-A5E7-EAF25B1DEC8A
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/10847128
PubMed ID	10847128
published in	wds:Q29619747-CD611A09-DF8C-45BB-9EA5-51343AFFDD3A
published in	Journal of Viral Hepatitis
issue	wds:Q29619747-8336CC8E-2F16-4A4A-B8AA-41C6DE426903
volume	wds:Q29619747-ABEB3AD2-B6D8-4DDA-96DB-1F867350003C
issue	1
volume	6
DOI	wds:Q29619747-7E9F285D-E473-4178-BF81-247B44695270
DOI	http://dx.doi.org/10.1046/J.1365-2893.1999.6120139.X
DOI	10.1046/J.1365-2893.1999.6120139.X
ResearchGate publication ID	wds:Q29619747-088035FB-AF88-4009-845A-7EAD3711BE77
ResearchGate publication ID	224762836
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q29619747
is cites work of	Candidate hepatitis C vaccine trials and people who inject drugs: challenges and opportunities Cost effectiveness of interferon alpha or peginterferon alpha with ribavirin for histologically mild chronic hepatitis C. Monoclonal Antibody AP33 Defines a Broadly Neutralizing Epitope on the Hepatitis C Virus E2 Envelope Glycoprotein Structurally conserved amino Acid w501 is required for RNA helicase activity but is not essential for DNA helicase activity of hepatitis C virus NS3 protein. Incidence and risk factors for hepatitis C infection in a cohort of women in rural Egypt Hepatitis C virus suppresses the IRE1-XBP1 pathway of the unfolded protein response Functional properties of a monoclonal antibody inhibiting the hepatitis C virus RNA-dependent RNA polymerase Identification of Conserved Residues in the E2 Envelope Glycoprotein of the Hepatitis C Virus That Are Critical for CD81 Binding Characterization of the hepatitis C virus E2 epitope defined by the broadly neutralizing monoclonal antibody AP33. High-Affinity Aptamers to Subtype 3a Hepatitis C Virus Polymerase Display Genotypic Specificity Hepatitis B virus and hepatitis C virus in pregnant Sudanese women Substrate complexes of hepatitis C virus RNA polymerase (HC-J4): structural evidence for nucleotide import and de-novo initiation Antibody to E1 peptide of hepatitis C virus genotype 4 inhibits virus binding and entry to HepG2 cells in vitro Broadly neutralizing human monoclonal antibodies to the hepatitis C virus E2 glycoprotein Identification and characterization of coumestans as novel HCV NS5B polymerase inhibitors. Frequencies of HCV-specific effector CD4+ T cells by flow cytometry: correlation with clinical disease stages Risk factors associated with Hepatitis C among female substance users enrolled in community-based HIV prevention studies Hepatitis C virus (HCV)--specific T cell responses in injection drug users with apparent resistance to HCV infection Seroprevalence and Risk Factors of Hepatitis C Virus among Juveniles in Correctional Center in Isfahan, Iran HCV-related burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity, and mortality Stable Cytotoxic T Cell Escape Mutation in Hepatitis C Virus Is Linked to Maintenance of Viral Fitness Cost-effectiveness of pegylated interferon and ribavirin for patients with chronic hepatitis C treated in routine clinical practice. HLA class I allelic diversity and progression of fibrosis in patients with chronic hepatitis C A ribonuclease zymogen activated by the NS3 protease of the hepatitis C virus Sepsis: in search of cure. Sofosbuvir, a nucleotide polymerase inhibitor, for the treatment of chronic hepatitis C virus infection Phosphorylation of hepatitis C virus nonstructural protein 5A modulates its protein interactions and viral RNA replication The hepatitis C viral NS3 protein is a processive DNA helicase with cofactor enhanced RNA unwinding Spontaneous recovery in acute human hepatitis C virus infection: functional T-cell thresholds and relative importance of CD4 help NS5A inhibitor, daclatasvir, for the treatment of chronic hepatitis C virus infection. Hyperphosphorylation of the hepatitis C virus NS5A protein requires an active NS3 protease, NS4A, NS4B, and NS5A encoded on the same polyprotein Liver-Infiltrating Lymphocytes in Chronic Human Hepatitis C Virus Infection Display an Exhausted Phenotype with High Levels of PD-1 and Low Levels of CD127 Expression Upregulation of PD-1 Expression on Circulating and Intrahepatic Hepatitis C Virus-Specific CD8+ T Cells Associated with Reversible Immune Dysfunction wd:Q27620489 Determinants for membrane association of the hepatitis C virus RNA-dependent RNA polymerase Modulation of the hepatitis C virus RNA-dependent RNA polymerase activity by the non-structural (NS) 3 helicase and the NS4B membrane protein. Oligomeric interaction of hepatitis C virus NS5B is critical for catalytic activity of RNA-dependent RNA polymerase Worldwide variation in the relative importance of hepatitis B and hepatitis C viruses in hepatocellular carcinoma: a systematic review Viral hepatitis: new data on hepatitis C infection Burden of pediatric hepatitis C Molecular Mechanism of Hepatitis C Virus Replicon Variants with Reduced Susceptibility to a Benzofuran Inhibitor, HCV-796 HCV796: A selective nonstructural protein 5B polymerase inhibitor with potent anti-hepatitis C virus activity in vitro, in mice with chimeric human livers, and in humans infected with hepatitis C virus Direct acting antivirals for the treatment of chronic viral hepatitis The global burden of cancer: priorities for prevention Hepatitis C and kidney transplantation An overview of HCV molecular biology, replication and immune responses

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software